Literature DB >> 6186840

Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components.

C S Raine, U Traugott.   

Abstract

Guinea pigs with long-standing chronic experimental autoimmune (allergic) encephalomyelitis were treated with myelin basic protein (MBP) alone in incomplete Freund's adjuvant or MBP in combination with a lipid hapten, galactocerebroside in incomplete Freund's adjuvant and studied for up to 26 months post-treatment. Animals which received MBP/galactocerebroside consistently displayed a long-lasting, marked, clinical improvement within 3 months post-treatment. Of 14 animals treated with MBP/galactocerebroside four have been sampled for light and electron microscopy. The central nervous systems of these animals displayed widespread remyelination and profound oligodendroglial proliferation. Some oligodendroglia appeared to be of recent origin. This structural recovery had occurred against a background of advanced gliosis and fibrosis. Treatment with MBP alone was associated with an initial period of stabilization, but after several months, relapsing activity and disease progression returned. It is suggested that after prolonged autoimmune demyelination, oligodendrocytes can proliferate in the presence of advanced scarring, that central nervous system remyelination can be effected, and that these findings have relevance to multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186840

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Optic nerve sheath decompression: neuropathologic, clinical, and hemodynamic results and rationale.

Authors:  R C Sergott
Journal:  Trans Am Ophthalmol Soc       Date:  1991

Review 2.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Cellular compensatory mechanisms in the CNS of dysmyelinated rats.

Authors:  Jacek M Kwiecien
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

4.  T cell autoimmunity to brain myelin.

Authors:  H Wekerle
Journal:  Surv Immunol Res       Date:  1984

5.  Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Laurie Zoecklein; Moses Rodriguez
Journal:  J Neurol Transl Neurosci       Date:  2014-01

6.  Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors:  J H Noseworthy; P C O'Brien; B G van Engelen; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  Myelin basic protein does not have a mitogenic effect on adult oligodendrocytes.

Authors:  G R Moore; S U Kim; E Chang; M Kim
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 8.  Mechanisms of virus-induced demyelination and remyelination.

Authors:  M Rodriguez
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.